Toolkit/bacteriophage-derived peptides

bacteriophage-derived peptides

Construct Pattern·Research·Since 2020

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Bacteriophage-derived peptides are peptide inhibitors reported to allosterically inhibit CRISPR-Cas9. Based on the supplied evidence, they act as anti-CRISPR-like modulators of Cas9 activity in genome editing contexts.

Usefulness & Problems

Why this is useful

These peptides are useful as molecular regulators of CRISPR-Cas9 because they provide a peptide-based route to suppress Cas9 activity. The supplied evidence supports their relevance to genome editing control, but does not provide detailed comparative performance data.

Problem solved

They address the problem of limiting or modulating CRISPR-Cas9 nuclease activity during editing applications. The evidence specifically supports allosteric inhibition of Cas9, but does not define the exact experimental use cases or operating window.

Problem links

Need controllable genome or transcript editing

Derived

Bacteriophage-derived peptides are peptide inhibitors reported to allosterically inhibit CRISPR-Cas9. Based on the supplied evidence, they function as anti-CRISPR-like modulators of Cas9 activity in genome editing contexts.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

editing

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuatoroperating role: regulatorswitch architecture: uncaging

Implementation is only supported at the level of using bacteriophage-derived peptides to inhibit CRISPR-Cas9. The provided evidence does not describe construct architecture, delivery method, expression strategy, dosage, or cofactor requirements.

The supplied evidence is limited to a title-level claim and does not specify peptide sequences, Cas9 ortholog scope, potency, structural determinants, or cellular validation details. Independent replication and breadth across editing systems cannot be established from the provided material.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 2inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 3inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 4inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 5inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 6inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 7inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 8inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 9inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 10inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 11inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 12inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 13inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 14inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 15inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 16inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Claim 17inhibitionsupports2020Source 1needs review

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Approval Evidence

1 source1 linked approval claimfirst-pass slug bacteriophage-derived-peptides
Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides

Source:

inhibitionsupports

Bacteriophage-derived peptides allosterically inhibit CRISPR-Cas9.

Source:

Comparisons

Source-backed strengths

A key strength is that inhibition is reported to occur through an allosteric mechanism rather than by simple active-site blockade. The evidence also indicates that the inhibitors are bacteriophage-derived peptides, supporting a compact peptide-based modality for Cas9 regulation.

bacteriophage-derived peptides and CRISPR-Cas genome editors directly modulated by temperature address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing

bacteriophage-derived peptides and microhomology templates address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing

bacteriophage-derived peptides and PMNT mixed with single-stranded DNA color reporter address a similar problem space because they share editing.

Shared frame: same top-level item type; shared target processes: editing

Ranked Citations

  1. 1.
    StructuralSource 1Genome biology2020Claim 12Claim 11Claim 11

    Extracted from this source document.